Dexcom Inc [NASDAQ: DXCM] loss -0.14% or -0.11 points to close at $76.44 with a heavy trading volume of 7419501 shares.
It opened the trading session at $76.99, the shares rose to $77.835 and dropped to $75.5501, the range by which the price of stock traded the whole day. The daily chart for DXCM points out that the company has recorded 8.12% gains over the past six months.
If we look at the average trading volume of 3.92M shares, DXCM reached to a volume of 7419501 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Dexcom Inc [DXCM]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DXCM shares is $103.62 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DXCM stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Dexcom Inc shares, keeping their opinion on the stock as Perform, with their previous recommendation back on September 08, 2025. While these analysts kept the previous recommendation, Argus raised their target price to Buy. The new note on the price target was released on August 21, 2025, representing the official price target for Dexcom Inc stock. Previously, the target price had yet another raise to $102, while Truist analysts kept a Buy rating on DXCM stock.
The Price to Book ratio for the last quarter was 11.65, with the Price to Cash per share for the same quarter was set at 7.47. Price to Free Cash Flow for DXCM in the course of the last twelve months was 52.52 with Quick ratio for the last quarter at 1.35.
Trading performance analysis for DXCM stock
Dexcom Inc [DXCM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.58. With this latest performance, DXCM shares dropped by -5.42% in over the last four-week period, additionally plugging by 8.12% over the last 6 months – not to mention a drop of -1.71% in the past year of trading.
Dexcom Inc [DXCM]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Dexcom Inc [DXCM] shares currently have an operating margin of 15.98% and a Gross Margin at 58.77%. Dexcom Inc’s Net Margin is presently recorded at 13.29%.
Dexcom Inc (DXCM) Capital Structure & Debt Analysis
According to recent financial data for Dexcom Inc. ( DXCM), the Return on Equity (ROE) stands at 22.83%, reflecting robust shareholder value creation. The Return on Assets (ROA) is 8.09%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Dexcom Inc’s Return on Invested Capital (ROIC) is 14.57%, showcasing its effectiveness in deploying capital for earnings.
Dexcom Inc (DXCM) Efficiency & Liquidity Metrics
Based on Dexcom Inc’s (DXCM) latest financial statements, the Debt-to-Equity Ratio is 1.00%, indicating its reliance on debt financing relative to shareholder equity.
Dexcom Inc (DXCM) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Dexcom Inc. (DXCM) effectively leverages its workforce, generating an average of $55485.44 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.52% and a Quick Ratio of 1.35%, indicating strong ability to cover short-term liabilities.
Dexcom Inc [DXCM]: An earnings per share (EPS) analysis
With the latest financial reports released by the company, Dexcom Inc posted 0.45/share EPS, while the average EPS was predicted by analysts to be reported at 0.43/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.02. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DXCM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Dexcom Inc go to 24.60%.
An analysis of Institutional ownership at Dexcom Inc [DXCM]
There are presently around $97.51%, or 97.92%% of DXCM stock, in the hands of institutional investors. The top three institutional holders of DXCM stocks are: VANGUARD GROUP INC with ownership of 46.51 million shares, which is approximately 11.6516%. BLACKROCK INC., holding 34.52 million shares of the stock with an approximate value of $$3.91 billion in DXCM stocks shares; and BLACKROCK INC., currently with $$1.85 billion in DXCM stock with ownership which is approximately 4.0853%.
